David Nathanson

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: DIABETIC MEDICINE. 2024;41(5):e15259
Standardising personalised diabetes care across European health settings: A person-centred outcome set agreed in a multinational Delphi study
Porth A-K; Huberts AS; Rogge A; Benard AHM; Forbes A; Strootker A; Del Pozo CH; Kownatka D; Hopkins D; Nathanson D; Aanstoot H-J; Soderberg J; Eeg-Olofsson K; Hamilton K; Delbecque L; Ninov L; Due-Christensen M; Leutner M; Simo R; Vikstrom-Greve S; Roessner S; Flores V; Seidler Y; Hasler Y; Stamm T; Kautzky-Willer A
Article: BMJ OPEN. 2023;13(4):e069037
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study
Ritsinger V; Bodegard J; Kristofi R; Thuresson M; Nathanson D; Nystrom T; Eriksson J; Norhammar A
Article: ENDOCRINE. 2023;79(3):455-458
Hypoglycemia after exposure of diclofenac medication
Falhammar H; Torring O; Larsson M; Nathanson D
Article: CARDIOVASCULAR DIABETOLOGY. 2022;21(1):282
Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data
Kristofi R; Bodegard J; Ritsinger V; Thuresson M; Nathanson D; Nystrom T; Norhammar A; Eriksson JW
Article: DIABETES CARE. 2022;45(12):3040-3049
Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study
Brinck J; Hagstrom E; Natman J; Franzen S; Eeg-Olofsson K; Nathanson D; Eliasson B
Article: LAKARTIDNINGEN. 2022;119:21210
[Digiphysical cascade screening model to diagnose familial hypercholesterolemia in relatives to an index case].
Littmann K; Kindborg G; Nathanson D; Brinck J
Article: DIABETOLOGIA. 2021;64(7):1595-1603
Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls
Nathanson D; Svensson A-M; Miftaraj M; Franzen S; Bolinder J; Eeg-Olofsson K
Article: DIABETES CARE. 2021;44(5):1211-1218
Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study
Kristofi R; Bodegard J; Norhammar A; Thuresson M; Nathanson D; Nystrom T; Birkeland KI; Eriksson JW
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2020;105(10):dgaa194-e3705
Associations Between Antihypertensive Medications and Severe Hyponatremia: A Swedish Population-Based Case-Control Study
Falhammar H; Skov J; Calissendorff J; Nathanson D; Lindh JD; Mannheimer B
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29(1):77-83
Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden: A population-based register study
Bergh CF; Toivanen S; Johnell K; Calissendorff J; Skov J; Falhammar H; Nathanson D; Lindh JD; Mannheimer B
Article: DIABETES, OBESITY AND METABOLISM. 2019;21(12):2651-2659
Dapagliflozin vs non-SGLT-2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE-TIMI 58 trial: A nationwide observational study
Norhammar A; Bodegard J; Nystrom T; Thuresson M; Rikner K; Nathanson D; Eriksson JW
Article: ACTA NEUROLOGICA SCANDINAVICA. 2019;140(6):443-448
Prehospital exenatide in hyperglycemic stroke-A randomized trial
Larsson M; Castren M; Lindstrom V; von Euler M; Patrone C; Wahlgren N; Nathanson D
Article: ENDOCRINE. 2019;66(3):660-665
Sex-specific risks of death in patients hospitalized for hyponatremia: a population-based study
Mannheimer B; Skov J; Falhammar H; Calissendorff J; Lindh JD; Nathanson D
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2019;69:20-24
Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study
Falhammar H; Calissendorff J; Skov J; Nathanson D; Lindh JD; Mannheimer B
Article: CARDIOVASCULAR DIABETOLOGY. 2019;18(1):91
GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals
Larsson M; Patrone C; von Euler M; Holst JJ; Nathanson D
Article: DIABETES, OBESITY AND METABOLISM. 2019;21(5):1136-1145
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study
Norhammar A; Bodegard J; Nystrom T; Thuresson M; Nathanson D; Eriksson JW
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2019;60:71-77
Antipsychotics and severe hyponatremia: A Swedish population-based case-control study
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2019;59:65-69
Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Article: PHARMACOECONOMICS - OPEN. 2018;2(4):393-402
Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006-2014
Nathanson D; Sabale U; Eriksson JW; Nystrom T; Norhammar A; Olsson U; Bodegard J
Article: ENDOCRINOLOGY, DIABETES & METABOLISM. 2018;1(4):e00036
Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study
Persson F; Bodegard J; Lahtela JT; Nystrom T; Jorgensen ME; Jensen ML; Gulseth HL; Thuresson M; Hoti F; Nathanson D; Norhammar A; Birkeland KI; Eriksson JG; Eriksson JW
Article: SEIZURE. 2018;59:28-33
Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population-based case-control study
Falhammar H; Lindh JD; Calissendorff J; Farmand S; Skov J; Nathanson D; Mannheimer B
Article: ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2018;6(1):14
Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin
Lietzau G; Davidsson W; Ostenson C-G; Chiazza F; Nathanson D; Pintana H; Skogsberg J; Klein T; Nystrom T; Darsalia V; Patrone C
Article: LAKARTIDNINGEN. 2018;115:EXDT
Många läkemedel – både nya och gamla – sänker blodglukos - För att ge patienten optimal läkemedelsbehandling krävs kännedom om patofysiologi och verkningsmekanismer.
Nyström T; Nathanson D
Article: DIABETES, OBESITY AND METABOLISM. 2018;20(2):344-351
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study
Persson F; Nystrom T; Jorgensen ME; Carstensen B; Gulseth HL; Thuresson M; Fenici P; Nathanson D; Eriksson JW; Norhammar A; Bodegard J; Birkeland KI
Article: AMERICAN JOURNAL OF MEDICINE. 2018;131(1):56-63
Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia
Farmand S; Lindh JD; Calissendorff J; Skov J; Falhammar H; Nathanson D; Mannheimer B
Article: BMJ OPEN. 2017;7(10):e016311
Safety of thrombolysis in stroke mimics: an observational cohort study from an urban teaching hospital in Sweden
Kostulas N; Larsson M; Kall T-B; von Euler M; Nathanson D
Article: THE LANCET DIABETES AND ENDOCRINOLOGY. 2017;5(9):709-717
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis
Birkeland KI; Jorgensen ME; Carstensen B; Persson F; Gulseth HL; Thuresson M; Fenici P; Nathanson D; Nystrom T; Eriksson JW; Bodegard J; Norhammar A
Article: DIABETES, OBESITY AND METABOLISM. 2017;19(6):831-841
Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetese
Nystrom T; Bodegard J; Nathanson D; Thuresson M; Norhammar A; Eriksson JW
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2017;123:199-208
Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia
Nystrom T; Bodegard J; Nathanson D; Thuresson M; Norhammard A; Eriksson JW
Article: BIOSCIENCE REPORTS. 2016;36(6):e00421
Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4
Larsson M; Lietzau G; Nathanson D; Ostenson C-G; Mallard C; Johansson ME; Nystrom T; Patrone C; Darsalia V
Article: DIABETOLOGIA. 2016;59(8):1692-1701
Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013
Norhammar A; Bodegard J; Nystrom T; Thuresson M; Eriksson JW; Nathanson D
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2016;117:39-47
Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality
Eriksson JW; Bodegard J; Nathanson D; Thuresson M; Nystrom T; Norhammare A
Article: DIABETES, OBESITY AND METABOLISM. 2016;18(5):537-541
Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor
Darsalia V; Larsson M; Lietzau G; Nathanson D; Nystrom T; Klein T; Patrone C
Article: DIABETOLOGY AND METABOLIC SYNDROME. 2016;8:5
Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure
Nathanson D; Frick M; Ullman B; Nystrom T
Article: PLOS ONE. 2016;11(6):e0156867
Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieu
Mansouri S; Lietzau G; Lundberg M; Nathanson D; Nystrom T; Patrone C
Article: LAKARTIDNINGEN. 2015;112:DF37
[Vitamin D intoxication caused by drugs bought online. Sky high daily dosage for six months resulted in severe hypercalcemia].
Mannheimer B; Törring O; Nathanson D
Article: REGULATORY PEPTIDES. 2014;190:25-31
Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice
Darsalia V; Olverling A; Larsson M; Mansouri S; Nathanson D; Nystrom T; Klein T; Sjoholm A; Patrone C
Article: STROKE RESEARCH AND TREATMENT. 2014;2014:747458-7
Sex, diastolic blood pressure, and outcome after thrombolysis for ischemic stroke.
Nathanson D; Patrone C; Nyström T; von Euler M
Article: PLOS ONE. 2014;9(8):e103114
Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization
Darsalia V; Hua S; Larsson M; Mallard C; Nathanson D; Nystroem T; Sjoeholm A; Johansson ME; Patrone C
Article: DIABETOLOGIA. 2012;55(4):926-935
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety
Nathanson D; Ullman B; Lofstrom U; Hedman A; Frick M; Sjoholm A; Nystrom T
Article: DIABETIC MEDICINE. 2011;28(3):301-305
Plasma levels of glucagon like peptide-1 associate with diastolic function in elderly men
Nathanson D; Zethelius B; Berne C; Lind L; Andren B; Ingelsson E; Holst JJ; Nystroem T
Article: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2010;325(1-2):26-35
Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor
Erdogdu O; Nathanson D; Sjoholm A; Nystrom T; Zhang Q
Article: DIABETOLOGIA. 2010;53(2):277-280
Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart disease
Nathanson D; Zethelius B; Berne C; Holst JJ; Sjoholm A; Nystrom T
Article: REGULATORY PEPTIDES. 2009;157(1-3):8-13
Endothelial dysfunction induced by triglycerides is not restored by exenatide in rat conduit arteries ex vivo
Nathanson D; Erdogdu O; Pernow J; Zhang Q; Nystrom T
Article: LAKARTIDNINGEN. 2005;102(16):1231-1233
[Amiodarone treatment against atrial fibrillation caused thyrotoxicosis].
Nathanson D; Calissendorff J; Lindhe C; Röjdmark S
Visa fler

Alla övriga publikationer

Review: PATIENT EDUCATION AND COUNSELING. 2023;116:107933
Which diabetes specific patient reported outcomes should be measured in routine care? A systematic review to inform a core outcome set for adults with Type 1 and 2 diabetes mellitus: The European Health Outcomes Observatory (H2O) programme
Hamilton K; Forde R; Due-Christensen M; Eeg-Olofson K; Nathanson D; Rossner S; Vikstrom-Greve S; Porth A-K; Seidler Y; Kautzky-Willer A; Delbecque L; Saltik AZO; Hasler Y; Floresi V; Stamm T; Hopkins D; Forbes A
Corrigendum: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2021;92:142-143
Antipsychotics and severe hyponatremia: A Swedish population-based case-control study (vol 60, pg 71, 2019)
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Corrigendum: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2021;92:140-141
Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study (vol 69, pg 20, 2019)
Falhammar H; Calissendorff J; Skov J; Nathanson D; Lindh JD; Mannheimer B
Corrigendum: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2021;91:107-108
Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study (vol 59, pg 65, 2019)
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Corrigendum: AMERICAN JOURNAL OF MEDICINE. 2021;134(4):554
Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia (vol 131, pg 56, 2017)
Farmand S; Lindh JD; Calissendorff J; Skov J; Falhammar H; Nathanson D; Mannheimer B
Corrigendum: ENDOCRINE. 2021;71(2):531
Sex-specific risks of death in patients hospitalized for hyponatremia: a population-based study (vol 66, pg 660, 2019)
Mannheimer B; Skov J; Falhammar H; Calissendorff J; Lindh JD; Nathanson D
Corrigendum: SEIZURE. 2021;84:99-100
Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population-based case-control study (vol 59, pg 28, 2018)
Falhammar H; Lindh JD; Calissendorff J; Farmand S; Skov J; Nathanson D; Mannheimer B
Letter: DIABETES CARE. 2018;41(6):e104-e105
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10
Nystrom T; Bodegard J; Nathanson D; Thuresson M; Norhammar A; Eriksson JW
Review: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2015;35(5):718-723
Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke
Darsalia V; Larsson M; Nathanson D; Klein T; Nystrom T; Patrone C
Review: REVIEWS IN ENDOCRINE AND METABOLIC DISORDERS. 2014;15(3):233-242
GLP-1R activation for the treatment of stroke: Updating and future perspectives
Darsalia V; Nathanson D; Nystrom T; Klein T; Sjoholm A; Patrone C
Thesis / dissertation: 2010
Studies on incretins and cardiovascular function
Nathanson, David
Review: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2009;297(1-2):112-126
Hypoglycemic pharmacological treatment of type 2 diabetes: Targeting the endothelium
Nathanson D; Nystrom T

Anställningar

Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2023-2026

Examina och utbildning

Docent, internmedicin, Karolinska Institutet, 2020
Medicine Doktorsexamen, Institutionen för klinisk forskning o utbildning, Södersjukhuset, Karolinska Institutet, 2010
Läkarexamen, Karolinska Institutet, 1995

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI